Vaxart reports 100% survival for oral H5N1 vaccine in ferrets

Vaxart said peer-reviewed preclinical data for its oral H5N1 vaccine candidate VXA-H5-02 showed 100% survival in a lethal ferret challenge and reduced viral load. The candidate has not been evaluated in humans.